Clinical PARP inhibitors (PARPis) and determinants of response and... | Download Scientific Diagram
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response | eLife
Frontiers | Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy | Molecular Biosciences
PDF) 284 Differential Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Frontiers | Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy | Pharmacology
Ingo Hartung on Twitter: "First disclosure of #PARP1 selective inhibitor & trapper #AZD5305 at #AACR21: A 2nd generation PARP inhibitor for BRCA-mutated tumors with the potential for reduced haemato-toxicity (based on preclinical
Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance: Trends in Molecular Medicine
Advances and perspectives of PARP inhibitors | Experimental Hematology & Oncology | Full Text
IJMS | Free Full-Text | Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy | HTML
PARP1, but not PARP2, deletion desensitizes cells to clinical PARP... | Download Scientific Diagram
Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs | Nature Communications
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer
![PDF] Trapping Poly(ADP-Ribose) Polymerase | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbe86dab2123b788257c1ce8ce9e3e33589d3a24/3-Figure1-1.png "PDF] Trapping Poly(ADP-Ribose) Polymerase | Semantic Scholar")
PDF] Trapping Poly(ADP-Ribose) Polymerase | Semantic Scholar
![PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e573d959ed1d8f231c3d4154ee1cac839c065548/4-Figure1-1.png "PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar")
PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar
Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells | Oncogene
Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy - Zuo - 2021 - Journal of Molecular Recognition - Wiley Online Library
Clinical PARP inhibitors (PARPis) and determinants of response and... | Download Scientific Diagram
PARP inhibitors in cancer treatment | OncologyPRO
PARP inhibitors in ovarian cancer - Cancer Treatment Reviews
![PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e573d959ed1d8f231c3d4154ee1cac839c065548/5-Figure2-1.png "PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar")
PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response | eLife
When and How to Use PARP Inhibitors in Prostate Cancer: A Systematic Review of the Literature with an Update on On-Going Trials - European Urology Oncology
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
Unsprung traps keep PARP inhibitors effective | Nature Cell Biology
